clofibrate has been researched along with ozagrel in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 2 (66.67) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (33.33) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
Fujitani, H; Mitsukawa, M; Suga, T; Utsugi, M; Watanabe, T | 1 |
Horie, S; Suga, T; Watanabe, T; Yamada, J | 1 |
3 other study(ies) available for clofibrate and ozagrel
Article | Year |
---|---|
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Hypolipidemic effect and enhancement of peroxisomal beta-oxidation in the liver of rats by sodium-(E)-3-(4-(3-pyridylmethyl)phenyl)-2-methyl propenoate (OKY-1581), a potent inhibitor of TxA2 synthetase.
Topics: Acrylates; Animals; Clofibrate; Hypolipidemic Agents; Lipid Metabolism; Liver; Male; Methacrylates; Microbodies; Mitochondria, Liver; Organ Size; Oxidation-Reduction; Rats; Rats, Inbred Strains; Thromboxane-A Synthase | 1986 |
Participation of peroxisomal beta-oxidation system in the chain-shortening of a xenobiotic acyl compound.
Topics: Acrylates; Administration, Oral; Animals; Clofibrate; Cyanides; Liver; Male; Methacrylates; Microbodies; Rats; Rats, Inbred Strains; Time Factors | 1984 |